Current in vitro human erythroid culture platforms require abnormally high cytokine supplementation and use lower cell density (6/mL) compared with that present in bone marrow during physiologic erythropoiesis. These in vitro culture conditions limit extracellular interactions, are not dynamic, and exhaust stem and progenitor cell pools, thereby limiting culture longevity. We have developed a three-dimensional hollow fibre perfusion bioreactor (HFBR) comprised of a collagen-coated polyurethane scaffold which surrounded ceramic hollow fibres (HFs) and expanded dense inocula of human umbilical cord blood (CB) mononuclear cells (MNCs; >107/mL) when perfused with cytokine-free media in long-term culture. In order to study the role of this manuf...
Haematopoiesis is the process of blood production in the bone marrow (BM) tissue within the bones an...
The feasibility of ex vivo blood production is limited by both biological and engineering challenges...
BACKGROUND: There is no appropriate alternative source of red blood cells (RBCs) to relieve the wors...
Traditional culture systems for human erythropoiesis lack microenvironmental niches, spatial marrow ...
Successful ex vivo production of RBCs from human umbilical cord blood (hUCB) for transfusion would r...
Traditional ex vivo hematopoietic culture systems rely on liquid suspension cultures, where differen...
Erythropoiesis studies have been hampered by the lack of culture systems that accurately reproduce t...
We have developed a hematopoietic co-culture system using the hollow fiber bioreactor (HFBR) as a po...
Stem cell-derived erythroid cells hold great potential for the treatment of blood-loss anemia and fo...
Tissue vasculature efficiently distributes nutrients, removes metabolites, and possesses selective c...
Tissue vasculature efficiently distributes nutrients, removes metabolites, and possesses selective c...
Reproduction of dynamic physiologic erythropoiesis in vitro requires a three-dimensional (3D) archit...
Background aims. With the increasing scale in stem cell production, a robust and controlled cell exp...
Background aims. With the increasing scale in stem cell production, a robust and controlled cell exp...
Umbilical cord blood (UCB) has been shown as a convenient source of hematopoietic stem cells (HSCs) ...
Haematopoiesis is the process of blood production in the bone marrow (BM) tissue within the bones an...
The feasibility of ex vivo blood production is limited by both biological and engineering challenges...
BACKGROUND: There is no appropriate alternative source of red blood cells (RBCs) to relieve the wors...
Traditional culture systems for human erythropoiesis lack microenvironmental niches, spatial marrow ...
Successful ex vivo production of RBCs from human umbilical cord blood (hUCB) for transfusion would r...
Traditional ex vivo hematopoietic culture systems rely on liquid suspension cultures, where differen...
Erythropoiesis studies have been hampered by the lack of culture systems that accurately reproduce t...
We have developed a hematopoietic co-culture system using the hollow fiber bioreactor (HFBR) as a po...
Stem cell-derived erythroid cells hold great potential for the treatment of blood-loss anemia and fo...
Tissue vasculature efficiently distributes nutrients, removes metabolites, and possesses selective c...
Tissue vasculature efficiently distributes nutrients, removes metabolites, and possesses selective c...
Reproduction of dynamic physiologic erythropoiesis in vitro requires a three-dimensional (3D) archit...
Background aims. With the increasing scale in stem cell production, a robust and controlled cell exp...
Background aims. With the increasing scale in stem cell production, a robust and controlled cell exp...
Umbilical cord blood (UCB) has been shown as a convenient source of hematopoietic stem cells (HSCs) ...
Haematopoiesis is the process of blood production in the bone marrow (BM) tissue within the bones an...
The feasibility of ex vivo blood production is limited by both biological and engineering challenges...
BACKGROUND: There is no appropriate alternative source of red blood cells (RBCs) to relieve the wors...